Hero image with Pittsburgh background pittplusme.org/study/1392

STUDY BASICS

Have you been diagnosed with chronic plaque psoriasis for at least the past 6 months? If so, you may be eligible for a study to help researchers compare the effectiveness and safety of two treatments for psoriasis that have been successful in some patients. Study involves 15 in-person visits, lasting about 1 hour each, over 6 months. Compensation provided.


IRB:
  Pro00028957 - Eli Lilly and Company – US – 11F-MC-RHCR, A 24-Week Multicenter, Randomized, Double-Blind, Parallet-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients with Moderate-to-Severe-Plaque Psoriasis (Pro00028957)

RESEARCH AREAS:
  Featured Research

Age Range
AGE:   18 and up

Duration DURATION:  6 months
VISITS:  15

Location LOCATION: 
Falk Medical Building - Oakland
Compensation COMPENSATION: 

$50.00 per visit

Phone Number PHONE NUMBER:
1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1392
OR
Phone Number PHONE NUMBER:
1-866-438-8230

MEET THE RESEARCHER


Laura Ferris

Laura Korb Ferris, MD, PhD, is Associate Professor of Dermatology at the University of Pittsburgh School of Medicine, and is also the Director of Clinical Trials for the Department of Dermatology. Dr. Ferris earned her doctorate in immunology from Johns Hopkins University and her medical degree from the University of Maryland.




PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet